SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-206671
Filing Date
2022-07-29
Accepted
2022-07-29 16:26:59
Documents
15
Period of Report
2022-07-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d372157d8k.htm   iXBRL 8-K 30408
2 EX-1.1 d372157dex11.htm EX-1.1 229073
3 EX-5.1 d372157dex51.htm EX-5.1 5060
7 GRAPHIC g372157dsp5.jpg GRAPHIC 6533
  Complete submission text file 0001193125-22-206671.txt   468607

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA sttk-20220729.xsd EX-101.SCH 2873
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sttk-20220729_lab.xml EX-101.LAB 18739
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sttk-20220729_pre.xml EX-101.PRE 11719
9 EXTRACTED XBRL INSTANCE DOCUMENT d372157d8k_htm.xml XML 3463
Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Filer) CIK: 0001680367 (see all company filings)

IRS No.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39593 | Film No.: 221121150
SIC: 2834 Pharmaceutical Preparations